+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Contrast Media Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Contrast Media Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 162 Pages
  • Global
From
Neuroprotection Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Pediatric Neuroblastoma Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
Loading Indicator